[PDF][PDF] The First Case Report Of A Pregnancy After Exosome Therapy In Diminished Ovarian Reserve Patient

S Khodashenas - International Journal of Clinical and Medical Case …, 2024 - ijcmcr.com
Diminished ovarian reserve (DOR) is one of the causes of infertility. Some new research
focuses on mesenchymal stem cells (MSCs) in ovarian regeneration. MSCs exert their effect …

[HTML][HTML] Comparison of the therapeutic effects between stem cells and exosomes in primary ovarian insufficiency: as promising as cells but different persistency and …

H Park, RM Chugh, J Seok, E Cetin… - Stem cell research & …, 2023 - Springer
Background Primary ovarian insufficiency (POI) refers to the loss of ovarian function under
the age of 40 and results in amenorrhea and infertility. Our previous studies have shown that …

A review on the stem cell therapy and an introduction to exosomes as a new tool in reproductive medicine

U Kharazi, R Badalzadeh - Reproductive biology, 2020 - Elsevier
Stem cell therapy and exosome therapy are the two experimental methods that are now at
the center of attention. Various types of stem cells, especially mesenchymal stem cells and …

Exosomes and female infertility

X Sun, X Ma, X Yang, X Zhang - Current drug metabolism, 2019 - ingentaconnect.com
Background: Exosomes are small Extracellular Vesicles (EVs)(40-100 nm) secreted by living
cells and mediate the transmission of information between cells. The number and contents …

Role and mechanism of exosomes derived from mesenchymal stem cells in reproductive system diseases

S Zhao, J Zheng, W Qi, X Huang - Chinese Journal of Tissue Engineering …, 2021 - cjter.com
BACKGROUND: Mesenchymal stem cells are one of the most commonly used cell types in
regenerative medicine. In recent years, exosomes derived from mesenchymal stem cells …

[HTML][HTML] Fertility protection: a novel approach using pretreatment with mesenchymal stem cell exosomes to prevent chemotherapy–induced ovarian damage in a …

H Park, J Seok, E Cetin, MM Ghasroldasht… - American Journal of …, 2024 - Elsevier
Background Primary ovarian insufficiency refers to the loss of ovarian function before the
age of 40 years and leads to amenorrhea and infertility. Primary ovarian insufficiency has …

Enhanced Exosomes: A Breakthrough Therapy for Chemotherapy-Induced Premature Ovarian Insufficiency

MM Ghasroldasht, HS Park, FL Ali, A Beckman… - 2024 - researchsquare.com
Background Premature ovarian insufficiency (POI) presents a multifaceted challenge with
limited treatment options. This study explored the therapeutic potential of exosome-based …

[HTML][HTML] Mesenchymal stem cells-derived exosomes as a promising new approach for the treatment of infertility caused by polycystic ovary syndrome

M Izadi, ME Rezvani, A Aliabadi, M Karimi… - Frontiers in …, 2022 - frontiersin.org
Polycystic ovary syndrome (PCOS) is a multifactorial metabolic and most common endocrine
disorder that its prevalence, depending on different methods of evaluating PCOS traits …

EXOSOMES DERIVED FROM MENSTRUAL BLOOD-DERIVED STROMAL CELLS RESTORED OVARIAN FUNCTION IN RAT MODEL OF PREMATURE OVARIAN …

S Zhang, J Tan, P Li - Fertility and Sterility, 2020 - fertstert.org
Objective Premature ovarian insufficiency (POI) is one of the major causes of infertility. We
previously demonstrated that transplantation of menstrual blood-derived stromal cells …

[HTML][HTML] Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with …

P Igboeli, A El Andaloussi, U Sheikh, H Takala… - Journal of Medical Case …, 2020 - Springer
Background Premature ovarian failure is a relatively common condition that affects 1–3% of
adult women. Premature ovarian failure occurs when there is loss of ovarian function in …